Clinical trial

Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With…

NCT00062322 · Fox Chase Cancer Center, Other · Completed

Key facts

NCT number NCT00062322
Title Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer
Official title Phase I Study of Preoperative Chemo/Radiation (Concurrent Irinotecan/Cisplatin/RT) Followed by Surgery in Limited Stage Small Cell Lung Cancer (SCLC-LS)
Lead sponsor Fox Chase Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Lung Cancer
Intervention type Drug, Procedure, Radiation
Interventions cisplatin, irinotecan hydrochloride, conventional surgery, neoadjuvant therapy, radiation therapy
Start date Feb 1, 2003
Completion Oct 1, 2009
First posted Jun 6, 2003
Last update posted Feb 12, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies